Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $29.00 USD
Change Today +1.02 / 3.65%
Volume 1.8M
As of 8:04 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

ims health holdings inc (IMS) Snapshot

Open
$28.60
Previous Close
$27.98
Day High
$29.29
Day Low
$28.35
52 Week High
04/24/15 - $29.29
52 Week Low
05/19/14 - $22.75
Market Cap
9.7B
Average Volume 10 Days
511.0K
EPS TTM
$0.51
Shares Outstanding
335.4M
EX-Date
--
P/E TM
56.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for IMS HEALTH HOLDINGS INC (IMS)

ims health holdings inc (IMS) Related Businessweek News

View More BusinessWeek News

ims health holdings inc (IMS) Details

IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, prescriptions, electronic medical records, biomarkers, and government statistics that provide information about treatment patterns, disease progression, therapeutic switching, and concomitant diseases and treatments. In addition, the company offers a range of hosted and cloud-based applications, and associated implementation services; AnalyticsLink, software as a service based analytics solution; and MIDAS, which acts as a source of insight into international market dynamics. Further, it provides clinical solutions that help biopharmaceutical companies and clinical research organizations to design, plan, execute, and track clinical trials, as well as it integrates client data with company’s information and proprietary analytics that enable risk-sharing and pay-for-performance programs, network design and management, and population health management for payers and providers. The company primarily serves life science companies, including pharmaceutical, biotechnology, consumer health, and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers, and financial communities. IMS Health Holdings, Inc. was founded in 1954 and is based in Danbury, Connecticut.

10,200 Employees
Last Reported Date: 02/13/15
Founded in 1954

ims health holdings inc (IMS) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.6M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $457.5K
Senior Vice President of Global Services
Total Annual Compensation: $426.3K
Senior Vice President of Strategy & Global Pr...
Total Annual Compensation: $410.0K
Senior Vice President of Information Offering...
Total Annual Compensation: $402.0K
Compensation as of Fiscal Year 2014.

ims health holdings inc (IMS) Key Developments

IMS Health Holdings, Inc. Announces Preliminary Unaudited Earnings Results for the First Quarter Ended March 31, 2015; Reaffirms Earnings Guidance for the Full Year of 2015

IMS Health Holdings, Inc. announced preliminary unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of $632 million against $645 million a year ago. Operating Income was $91 million against $67 million a year ago. Income before income taxes was $58 million against loss before income taxes of $37 million a year ago. Net income was $298 million against net loss of $24 million a year ago. Diluted earnings per share attributable to common shareholders were $0.86 against diluted loss per share attributable to common shareholders of $0.09 a year ago. Net cash provided by operating activities was $30 million against cash used in operating activities of $103 million a year ago. Capital expenditures were $9 million against $33 million a year ago. Adjusted EBITDA was $216 million against $217 million a year ago. Adjusted net income was $136 million against $70 million a year ago, the increase primarily due to lower interest expense and lower cash taxes. Adjusted pre-tax income was $145 million against $99 million a year ago. Diluted adjusted earnings per share attributable to common shareholders were $0.39 against $0.24 a year ago. Net debt was $3,330 million. Unlevered Free Cash Flow for the first quarter was $57 million, up $68 million from the same period last year. For 2015, the company reaffirms full-year 2015 constant currency guidance. The company expects core IMS Health (excluding the impact of the acquisition of Cegedim’s CRM and Strategic Data businesses) to have full-year 2015 constant currency growth of 5% to 6% in revenue, 7.5% to 8.5% in Adjusted EBITDA, 16 to 19% in Adjusted Net Income, and 11% to 14% in Adjusted Diluted Earnings per Share. Including the acquisition of Cegedim’s CRM and Strategic Data businesses (Combined business), IMS Health expects to have full-year 2015 constant currency growth of 19% to 20% in revenue, 13% to 14% in Adjusted EBITDA, 20% to 23% in Adjusted Net Income, and 15% to 18% in Adjusted Diluted Earnings per Share.

IMS Health Holdings, Inc. to Report Q1, 2015 Results on Apr 24, 2015

IMS Health Holdings, Inc. announced that they will report Q1, 2015 results Pre-Market on Apr 24, 2015

IMS Health Holdings, Inc., Q1 2015 Earnings Call, Apr 24, 2015

IMS Health Holdings, Inc., Q1 2015 Earnings Call, Apr 24, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMS:US $29.00 USD +1.02

IMS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Informatica Corp $48.16 USD +0.16
Inovalon Holdings Inc $26.67 USD -0.32
PAREXEL International Corp $67.49 USD +0.27
Teradata Corp $43.98 USD -0.47
Veeva Systems Inc $27.17 USD -0.24
View Industry Companies
 

Industry Analysis

IMS

Industry Average

Valuation IMS Industry Range
Price/Earnings 55.4x
Price/Sales 2.8x
Price/Book 4.1x
Price/Cash Flow 7.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMS HEALTH HOLDINGS INC, please visit www.imshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.